BACKGROUND: Earlier studies have shown an association between high-normal glucose and increasing glycosylated hemoglobin (HbA1c) levels and cardiovascular events. The objective of this investigation was to study the association between increasing levels of HbA1c in asymptomatic individuals without diabetes mellitus (DM) and coronary plaque characteristics. METHODS: The study population consisted of 1043 asymptomatic Korean individuals without DM who underwent 64-slice cardiac computed tomography angiography as part of a health screening evaluation. We excluded 147 individuals with known history of DM and/or fasting glucose of at least 126 mg/dl, no HbA1c data, or missing risk factor information. The associations between coronary atheroscle...
Background and Objectives:Hyperglycemia on hospital admission is a known important risk factor in pa...
Coronary Artery Disease (CAD) is the most prevalent cardiovascular disease, which remains the leadin...
OBJECTIVE: The American Diabetes Association (ADA) recently published new clinical guidelines in whi...
BACKGROUND: Abnormal glucose metabolism is a major determinant of coronary artery disease (CAD) and...
Background-—Hemoglobin A1c (HbA1c), a time-integrated marker of glycemic control, predicts risk of c...
Glycated hemoglobin (HbA1c) is associated with an increased risk of cardiovascular disease. The aim ...
Objective: Associations of glycated hemoglobin A1c (HbA1c) levels to incident coronary and cardiovas...
AIM:We examined whether glycated haemoglobin (HbA1c) is associated to carotid atherosclerosis in an ...
Glycosylated hemoglobin (HbA1c) is an established marker associated with cardiovascular risk, even i...
Background. The relationship between hemoglobin A1c (HbA1c) levels and the extent of coronary artery...
OBJECTIVE-This study sought to investigate an association of HbA1c (A1C) with incident heart failure...
BackgroundSeveral studies have suggested that elevated levels of hemoglobin A1c (HbA1c) are associat...
Introduction. Diabetes mellitus is an important risk factor for coronary artery disease, related to ...
The American Diabetes Association (ADA) recently published new clinical guidelines in which hemoglob...
The baseline coronary plaque burden is the most important factor for rapid plaque progression (RPP) ...
Background and Objectives:Hyperglycemia on hospital admission is a known important risk factor in pa...
Coronary Artery Disease (CAD) is the most prevalent cardiovascular disease, which remains the leadin...
OBJECTIVE: The American Diabetes Association (ADA) recently published new clinical guidelines in whi...
BACKGROUND: Abnormal glucose metabolism is a major determinant of coronary artery disease (CAD) and...
Background-—Hemoglobin A1c (HbA1c), a time-integrated marker of glycemic control, predicts risk of c...
Glycated hemoglobin (HbA1c) is associated with an increased risk of cardiovascular disease. The aim ...
Objective: Associations of glycated hemoglobin A1c (HbA1c) levels to incident coronary and cardiovas...
AIM:We examined whether glycated haemoglobin (HbA1c) is associated to carotid atherosclerosis in an ...
Glycosylated hemoglobin (HbA1c) is an established marker associated with cardiovascular risk, even i...
Background. The relationship between hemoglobin A1c (HbA1c) levels and the extent of coronary artery...
OBJECTIVE-This study sought to investigate an association of HbA1c (A1C) with incident heart failure...
BackgroundSeveral studies have suggested that elevated levels of hemoglobin A1c (HbA1c) are associat...
Introduction. Diabetes mellitus is an important risk factor for coronary artery disease, related to ...
The American Diabetes Association (ADA) recently published new clinical guidelines in which hemoglob...
The baseline coronary plaque burden is the most important factor for rapid plaque progression (RPP) ...
Background and Objectives:Hyperglycemia on hospital admission is a known important risk factor in pa...
Coronary Artery Disease (CAD) is the most prevalent cardiovascular disease, which remains the leadin...
OBJECTIVE: The American Diabetes Association (ADA) recently published new clinical guidelines in whi...